Vimarsana
Biggest News Aggregation in the World

Page 3 - Small Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Pharma Today - Breaking & Trending Today

Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business - Cybin (AMEX:CYBN), Small Pharma (OTC:DMTTF) - Vimarsana News

Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business - Cybin (AMEX:CYBN), Small Pharma (OTC:DMTTF)

Small Pharma Inc. (OTCQB: DMTTF), the short-acting psychedelics biotech about to be purchased by Cybin Inc.

Small Pharma Reports Fiscal Second Quarter 2024 Highlights - Vimarsana News

Small Pharma Reports Fiscal Second Quarter 2024 Highlights

• Shareholders overwhelmingly vote in favour of Cybin’s acquisition of Small Pharma, supporting the combined company’s vision to build an international...

Moving Closer To Cybin Acquisition, Small Pharma Obtains Final Order Approving Arrangement - Cybin (AMEX:CYBN), Small Pharma (OTC:DMTTF) - Vimarsana News

Moving Closer To Cybin Acquisition, Small Pharma Obtains Final Order Approving Arrangement - Cybin (AMEX:CYBN), Small Pharma (OTC:DMTTF)

Short-acting psychedelics biotech Small Pharma Inc.

Moving Closer To Cybin Acquisition, Small Pharma Obtains Final Order Approving Arrangement - Vimarsana News

Moving Closer To Cybin Acquisition, Small Pharma Obtains Final Order Approving Arrangement

Short-acting psychedelics biotech Small Pharma Inc. DMTTF has obtained a final order from the Supreme Court of British Columbia approving the announced plan…

Source: biztoc.com
Small Pharma Obtains Final Order Approving Arrangement - Vimarsana News

Small Pharma Obtains Final Order Approving Arrangement

Small Pharma Inc. ("Small Pharma"), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions and Cybin Inc. (NEO:CYBN) ("Cybin"), a clinical-stage biopharmaceutical company committed to...